• Niclosamide Workflows for STAT3 Cancer Research

  2026-08-26

  Niclosamide enables a practical, multi-endpoint workflow for connecting STAT3 Tyr-705 inhibition with viability loss, apoptosis, and G0/G1 arrest. Its use alongside ATRX-stratified glioma experiments and an acute myelogenous leukemia model helps distinguish pathway response from nonspecific cytotoxicity.

• Alpha-Ketoglutarate Workflows for Tumor Metabolism

  2026-08-26

  Build controlled alpha-ketoglutarate perturbation experiments for mitochondrial flux, enzyme activity, and tumor–macrophage signaling. This workflow guide translates a recent cholangiocarcinoma mechanism into practical dosing, assay-design, and troubleshooting decisions.

• PCNA–POLD1 Signaling in Cardiomyocyte Hypertrophy

  2026-08-25

  The reference study identifies PCNA–POLD1-mediated DNA synthesis and endoreplication as active drivers of pathological cardiomyocyte hypertrophy rather than passive markers of remodeling. Using genetic, biochemical, imaging, and human cardiomyocyte models, the authors show that increasing p21 or directly disrupting this pathway can reduce hypertrophic growth and improve diastolic function in a preclinical model.

• Angiotensin II: Protocols for Vascular Models

  2026-08-25

  Angiotensin II (SKU A1042) provides a defined peptide stimulus for receptor-signaling, vascular smooth muscle, hypertension, and vascular remodeling experiments. This guide covers preparation, exposure conditions, storage, and quality control; the material is for research use only and should not be used for diagnosis or treatment.

• Angiotensin II (A1042): Practical Research Guide

  2026-08-24

  Angiotensin II (A1042) provides a defined octapeptide stimulus for receptor signaling, vascular smooth muscle, oxidative-stress, hypertension, and vascular remodeling workflows. This guide explains preparation, dose selection, controls, and troubleshooting; the reagent is for research use only and should not be used for diagnosis, treatment, or direct clinical extrapolation.

• LL-37 Mimetics and Selective Antibiofilm Activity

  2026-08-24

  This 2017 study shows that truncating the human host-defense peptide LL-37 can preserve or improve selected antimicrobial activity, but does not automatically preserve its antibiofilm effects. By combining MIC testing, crystal violet biomass assays, XTT measurements, and lipopolysaccharide/lipoteichoic acid binding studies, the authors distinguish microbial killing from biofilm prevention and inhibition.

• Alpha-Ketoglutarate as a Causal Metabolic Probe

  2026-08-23

  Alpha-ketoglutarate is more than a TCA-cycle metabolite: it can be used to separate metabolic flux, extracellular accumulation, and immune-cell responses. This article translates recent PDHA1–α-KGA findings into a compartment-aware framework for rigorous biochemical and tumor-immunity assays.

• STING, CD40, and TLS in ESCC

  2026-08-22

  A 2025 study links tertiary lymphoid structures with favorable survival in treatment-naïve esophageal squamous cell carcinoma and identifies IRF4-positive tumor-infiltrating B cells as a central immune feature. Its mechanistic model proposes that CD40 and STING compete for TRAF2, engaging non-canonical NF-κB signaling to promote IRF4 expression and B-cell activation, with implications for biomarker development and cancer immunotherapy research.

• Plk1 Regulation of p31comet in MCC Disassembly

  2026-08-22

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet-driven mitotic checkpoint complex disassembly. By combining checkpoint extracts, purified proteins, kinase inhibition, and residue-specific mutagenesis, the authors show that Plk1 phosphorylation of p31comet at S102 restrains TRIP13-dependent Mad2 release and helps prevent premature checkpoint termination.

• APEX2, TERT, and DNA Repair in Human Stem Cells

  2026-08-21

  A 2024 bioRxiv preprint identifies APEX2, but not its paralog APEX1, as necessary for efficient TERT expression and telomerase activity in human embryonic stem cells and a melanoma cell line. RNA-seq and chromatin immunoprecipitation suggest that APEX2 may support TERT transcription by maintaining DNA integrity near damage-prone repetitive elements within the TERT locus.

• Tetramethylrhodamine ethyl ester perchlorate Workflow

  2026-08-20

  Turn mitochondrial membrane potential into a live-cell fluorescence readout with a practical TMRE workflow for microscopy and flow cytometry. This guide connects assay setup and troubleshooting to trichothecene-induced mitochondrial dysfunction, while clarifying what TMRE can—and cannot—demonstrate mechanistically.

• GPX3, JNK/c-Jun, and Gemcitabine Sensitivity

  2026-08-20

  The reference study identifies GPX3 as a potential tumor suppressor in pancreatic cancer, linking its loss to increased proliferation, migration, invasion, and reduced Gemcitabine sensitivity. Through gain-of-function and anisomycin rescue experiments, the authors place JNK/c-Jun signaling at the center of this phenotype while highlighting a testable mechanism for chemotherapy resistance.

• Betaine Hydrochloride for Enzyme Research

  2026-08-19

  Betaine hydrochloride, also called carboxymethyl(trimethyl)azanium chloride, is a water-soluble quaternary ammonium salt supplied as the N1700 research product. Its documented value is analytical and workflow control in biochemical research; the cited oridonin oncology study does not establish betaine hydrochloride as an anti-inflammatory or anticancer agent.

• ddhCTP: From Host Metabolite to Assay Design

  2026-08-19

  Explore how ddhCTP (3ʹ-deoxy-3′,4′-didehydro-CTP) converts viperin biology into a practical antiviral research strategy. This guide connects polymerase biochemistry, cellular validation, and recent coronavirus findings to improve assay interpretation and antiviral drug development.

• Angiotensin II: Mechanism and Research Protocols

  2026-08-18

  Angiotensin II is an endogenous octapeptide and potent vasopressor that activates angiotensin receptors through GPCR signaling. Its controlled use supports vascular smooth muscle cell hypertrophy research, hypertension mechanism study, and cardiovascular remodeling investigation.

7828 records 2/522 page Previous Next 12345 下5页 Last page